Atea Pharmaceuticals Inc. (NASDAQ:AVIR) Forecast to gain 199.47% to hit Consensus price target – Marketing Sentinel

Atea Pharmaceuticals Inc. (NASDAQ:AVIR) Forecast to gain 199.47% to hit Consensus price target

Atea Pharmaceuticals Inc. (NASDAQ:AVIR) has a beta value of 0 and has seen 1,628,461 shares traded in the last trading session. The company, currently valued at $2.04 Billion, closed the last trade at $24.71 per share which meant it lost -$1.67 on the day or -6.33% during that session. The AVIR stock price is -281.1% off its 52-week high price of $94.17 and 2.27% above the 52-week low of $24.15. If we look at the company’s 10-day average daily trading volume, we find that it stood at 416.27 Million shares traded. The 3-month trading volume is 309.79 Million shares.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

The consensus among analysts is that Atea Pharmaceuticals Inc. (AVIR) is a Buy stock at the moment, with a recommendation rating of 1.7. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 3 have rated it as a Hold, with 3 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is $0.16.

Atea Pharmaceuticals Inc. (NASDAQ:AVIR) trade information

Despite being -6.33% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on Monday, Apr 26 when the AVIR stock price touched $37.64- or saw a rise of 34.35%. Year-to-date, Atea Pharmaceuticals Inc. shares have moved -40.86%, while the 5-day performance has seen it change -32.13%. Over the past 30 days, the shares of Atea Pharmaceuticals Inc. (NASDAQ:AVIR) have changed -56.06%. Short interest in the company has seen 4.25 Million shares shorted with days to cover at 0.01.

Wall Street analysts have a consensus price target for the stock at $74, which means that the shares’ value could jump 199.47% from current levels. The projected low price target is $66 while the price target rests at a high of $82. In that case, then, we find that the current price level is +231.85% off the targeted high while a plunge would see the stock lose 167.1% from current levels.

Atea Pharmaceuticals Inc. (AVIR) estimates and forecasts

Earnings growth for 2021 is a modest +23.6%.

Atea Pharmaceuticals Inc. (NASDAQ:AVIR)’s Major holders

Insiders own 18.48% of the company shares, while shares held by institutions stand at 58.09% with a share float percentage of 71.26%. Investors are also buoyed by the number of investors in a company, with Atea Pharmaceuticals Inc. having a total of 99 institutions that hold shares in the company. The top two institutional holders are FMR, LLC with over 6.45 Million shares worth more than $269.38 Million. As of December 30, 2020, FMR, LLC held 7.79% of shares outstanding.

The other major institutional holder is Cormorant Asset Management, LP, with the holding of over 6.41 Million shares as of December 30, 2020. The firm’s total holdings are worth over $267.87 Million and represent 7.75% of shares outstanding.


5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored



Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Also the top two Mutual Funds that are holding company’s shares are Fidelity Growth Company Fund and Fidelity Series Growth Company Fund. As of February 27, 2021, the former fund manager holds about 3.64% shares in the company for having 3009767 shares of worth $226.82 Million while later fund manager owns 660.13 Thousand shares of worth $49.75 Million as of February 27, 2021, which makes it owner of about 0.8% of company’s outstanding stock.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Important Earnings

Insider Watchlist

We do not sell or share your information with anyone.